Back to search
FDAFDA · Food and drugs·Recall number D-0709-2023

oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6043-1.

Published May 31, 2023 · Recall initiated: April 28, 2023

Summary

FDA records drug Class II recall D-0709-2023, published May 31, 2023 and initiated April 28, 2023. Recalling firm: Central Admixture Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 5544 bags; Lot: Lot # 37-883938, Exp 05/02/2023; 37-884910, 37-884915, Exp 05/07/2023; 37-886041, Exp 05/10/2023; 37-887515, 37-887520, Exp 05/16/2023; 37-888318, Exp 05/21/2023; 37-888847, Exp 05/22/2023; 37-890535, Exp 05/29/2023; 37-890957, Exp 05/30/2023; 37-891566, 37-891568, Exp 06/01/2023; 37-892156, Exp 06/05/2023; 37-893165, 37-893166, Exp 06/08/2023; 37-893994, 37-893995, Exp 06/12/2023; 37-895771, 37-895773, 37-895775, Exp 06/19/2023; 37-896614, Exp 06/21/2023; 37-900377, Exp 07/06/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Central Admixture Pharmacy Services, Inc.
Distributor
Nationwide in the USA.
Lot
Lot # 37-883938, Exp 05/02/2023; 37-884910, 37-884915, Exp 05/07/2023; 37-886041, Exp 05/10/2023; 37-887515, 37-887520, Exp 05/16/2023; 37-888318, Exp 05/21/2023; 37-888847, Exp 05/22/2023; 37-890535, Exp 05/29/2023; 37-890957, Exp 05/30/2023; 37-891566, 37-891568, Exp 06/01/2023; 37-892156, Exp 06/05/2023; 37-893165, 37-893166, Exp 06/08/2023; 37-893994, 37-893995, Exp 06/12/2023; 37-895771, 37-895773, 37-895775, Exp 06/19/2023; 37-896614, Exp 06/21/2023; 37-900377, Exp 07/06/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 72185-6043-1. recalled?

Yes. FDA published recall D-0709-2023 on May 31, 2023. Reported hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail